Protease and reverse transcriptase mutation patterns in HIV type 1 isolates from heavily treated persons: comparison of isolates from Northern California with isolates from other regions. 2003

Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
Division of Infestious Diseases, Department of Medicine, Stanford University Medical Center, Stanford, CA 94305, USA.

We compared HIV-1 subtype B reverse transcriptase (RT) and protease mutation patterns in isolates from heavily treated persons in Northern California with those from persons described in the published literature predominantly from other parts of the United States and Europe. There were few differences in the prevalence of single, double, and triple mutations between the two sets of sequences. More complex patterns of mutations could be characterized by clustering the sequences into eight groups of RT sequences and nine groups of protease sequences according to the presence of known drug-resistance mutations. This clustering accounted for 63% of the variation at RT inhibitor-resistance positions and 68% of the variation at protease inhibitor-resistance positions. The majority of clusters contained Northern California and literature sequences in similar proportions.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002140 California State bounded on the east by Nevada and Arizona, on the south by Mexico and the Pacific Ocean on the south and west, and on the north by Oregon.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III
D016679 Genome, Viral The complete genetic complement contained in a DNA or RNA molecule in a virus. Viral Genome,Genomes, Viral,Viral Genomes
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
June 1998, Annals of internal medicine,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
May 2000, Journal of virological methods,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
October 2001, The Journal of infectious diseases,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
August 2009, Antiviral research,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
August 2004, Antimicrobial agents and chemotherapy,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
May 2003, Journal of acquired immune deficiency syndromes (1999),
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
July 2016, Journal of virology,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
April 2001, Journal of clinical microbiology,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
August 2012, AIDS research and human retroviruses,
Matthew J Gonzales, and Ilana Belitskaya, and Kathryn M Dupnik, and Soo-Yon Rhee, and Robert W Shafer
June 2008, Virus research,
Copied contents to your clipboard!